In this large cohort of 4,895 NGS molecularly profiled breast tumors, we observed a high prevalence of mutations in the PIK3CA-AKT1-PTEN pathway, in up to 72.7% of tumors across all breast cancer subtypes. The gene discussed is PTEN; the disease is breast cancer.